Pediatric Appendicitis Medication

  • Author: Robert K Minkes, MD, PhD; Chief Editor: Carmen Cuffari, MD   more...
 
Updated: Oct 26, 2011
 

Medication Summary

Administer 1 dose of preoperative antibiotics to children with suspected appendicitis. Antibiotics can be discontinued after surgery if no perforation is noted.

Antibiotics are selected to provide coverage for aerobic and anaerobic organisms. The most widely used regimen is the combination of ampicillin, clindamycin (or metronidazole), and gentamicin. Alternative regimens include the following:

  • Ampicillin/sulbactam
  • Cefoxitin
  • Cefotetan
  • Piperacillin/tazobactam
  • Ticarcillin/clavulanate
  • Imipenem/cilastatin

Resistant organisms develop in 15% of patients with a ruptured appendix. Antibiotic substitutions are made for patient allergies, poor clinical improvement or deterioration on current regimen, or culture-proven antibiotic resistance.

Patients with appendicitis also require medication for pain control. Antiemetic and antipyretic agents may also be indicated.

Antibiotic regimens should cover the most commonly encountered organisms, including Escherichia coli and Bacteroides, Klebsiella, Enterococcus, and Pseudomonas species.

Next

Penicillins

Class Summary

The penicillins are bactericidal antibiotics that work against sensitive organisms at adequate concentrations and inhibit the biosynthesis of cell wall mucopeptide. Examples of extended-spectrum penicillins include ticarcillin and clavulanate (Timentin) and ampicillin and sulbactam (Unasyn).

Ampicillin (Marcillin, Omnipen, Polycillin, Principen)

 

Ampicillin is a beta-lactam antibiotic with activity against some gram-positive and gram-negative organisms. It inhibits bacterial cell wall synthesis during active multiplication.

Ampicillin/sulbactam (Unasyn)

 

A combination of ampicillin with a beta-lactamase inhibitor, this agent has activity against some gram-positive organisms, gram-negative organisms (nonpseudomonal species), and anaerobic bacteria.

Piperacillin/tazobactam (Zosyn)

 

A combination of a beta-lactamase inhibitor with piperacillin, this agent has activity against some gram-positive organisms, gram-negative organisms, and anaerobic bacteria. It inhibits biosynthesis of bacterial cell wall mucopeptide and is effective during the stage of active multiplication.

Ticarcillin and clavulanate potassium (Timentin)

 

This combination of an antipseudomonal penicillin plus a beta-lactamase inhibitor provides coverage against most gram-positive and gram-negative organisms and most anaerobes. It inhibits biosynthesis of cell wall mucopeptide and is effective during the stage of active growth.

Imipenem and cilastatin (Primaxin)

 

This combination agent is indicated for treatment of multiple organism infections in which other agents do not have wide-spectrum coverage or are contraindicated because of potential for toxicity.

Previous
Next

Aminoglycosides

Class Summary

Aminoglycosides are bactericidal antibiotics used to primarily treat gram-negative infections. They interfere with bacterial protein synthesis by binding to 30S and 50S ribosomal subunits.

Gentamicin (Garamycin, Gentacidin)

 

Gentamicin is an aminoglycoside antibiotic with activity against gram-negative bacteria, including Pseudomonas species. It is synergistic with beta-lactams against enterococci. Gentamicin interferes with bacterial protein synthesis by binding to 30S and 50S ribosomal subunits. Dosing regimens are numerous; adjust the dose based on creatinine clearance and changes in volume of distribution. Gentamicin may be administered intravenously or intramuscularly.

Previous
Next

Anti-Infectives

Class Summary

Anti-infectives such as metronidazole and clindamycin are effective against some types of bacteria that have become resistant to other antibiotics.

Clindamycin (Cleocin)

 

Clindamycin is a lincosamide effective against gram-positive aerobic and anaerobic bacteria (except enterococci). It inhibits bacterial growth, possibly by blocking dissociation of peptidyl tRNA from ribosomes, causing RNA-dependent protein synthesis to arrest.

Metronidazole (Flagyl)

 

Metronidazole is often used in combination with an aminoglycoside, such as gentamycin. It provides broad gram-negative and anaerobic coverage. It appears to be absorbed into cells, and the intermediate-metabolized compounds that are formed bind DNA and inhibit protein synthesis, causing cell death. Metronidazole is a synthetic, nitroimadazole-derivative antibacterial and antiprotozoal agent. Metronidazole may be administered intravenously or orally.

Previous
Next

Cephalosporins

Class Summary

Cephalosporins are structurally and pharmacologically related to penicillins. They inhibit bacterial cell wall synthesis resulting in bactericidal activity.

Cefoxitin (Mefoxin)

 

A second-generation cephalosporin, cefoxitin has activity against some gram-positive organisms, gram-negative organisms (nonpseudomonal species), and anaerobic bacteria. It inhibits bacterial cell wall synthesis during active multiplication by binding 1 or more penicillin-binding proteins.

Cefotetan (Cefotan)

 

Cefotetan is a second-generation cephalosporin indicated for infections caused by susceptible gram-positive cocci and gram-negative rods.

Previous
Next

Analgesics

Class Summary

Pain management is a contentious topic for some emergency physicians and surgeons. Several classes of analgesic medications have proven to be safe and efficacious in the preoperative pediatric patient.

It is ethical and prudent for emergency physicians, surgeons, anesthesiologists, pediatricians, and pharmacists to agree on a plan for providing pain relief to the pediatric patient. Topics to be agreed upon include type, route, dose, and frequency of administration of analgesic drugs.

Ketorolac (Toradol)

 

Ketorolac inhibits prostaglandin synthesis by decreasing the activity of cyclooxygenase, which results in decreased formation of prostaglandin precursors.

With proper dosing, it does not cause a significant decrease in hematocrit, increase in creatinine, or overall complications. Its use can decrease hospital stay and narcotic requirements in children who have undergone surgery.

Fentanyl citrate (Sublimaze)

 

Fentanyl is a synthetic opioid that is 75-200 times more potent and has a much shorter half-life than morphine sulfate. It has less hypotensive effects and is safer in patients with hyperactive airway disease than morphine because of minimal to no associated histamine release. By itself, it causes little cardiovascular compromise, although the addition of benzodiazepines or other sedatives may result in decreased cardiac output and blood pressure.

Consider continuous infusion of fentanyl because of its short half-life (30-60 min). Parenteral fentanyl is the drug of choice for conscious sedation analgesia. It is ideal for analgesia of short duration during anesthesia and the immediate postoperative period. It is readily titrated and is easily and quickly reversed by naloxone.

After the initial parenteral dose, subsequent parenteral doses should not be titrated more frequently than every 3 or 6 hours. Fentanyl is highly lipophilic and protein bound. Prolonged exposure leads to accumulation in fat and delays the weaning process.

Morphine

 

Morphine sulfate has the advantages of reliable and predictable effects, a favorable safety profile, and ease of reversibility with naloxone. Various IV doses are used; it is commonly titrated until the desired effect is obtained.

The Joint Commission on the Accreditation of Healthcare Organizations has placed "MSO4" on the banned abbreviation list, because it can be mistaken for magnesium sulfate. Therefore, in writing the prescription, spell out "morphine sulfate" in full, legibly and clearly.

Previous
 
Contributor Information and Disclosures
Author

Robert K Minkes, MD, PhD  Professor of Surgery, University of Texas Southwestern Medical Center at Dallas, Southwestern Medical School; Medical Director and Chief of Surgical Services, Children's Medical Center of Dallas-Legacy Campus

Robert K Minkes, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Medical Association, American Pediatric Surgical Association, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Coauthor(s)

Kirsten A Bechtel, MD  Associate Professor, Department of Pediatrics, Yale University School of Medicine; Attending Physician, Department of Pediatric Emergency Medicine, Yale-New Haven Children's Hospital

Kirsten A Bechtel, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Deborah F Billmire, MD  Associate Professor, Department of Surgery, Indiana University Medical Center

Deborah F Billmire, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, American Pediatric Surgical Association, Phi Beta Kappa, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Michael Stephen Freitas, MS  State University of New York at Buffalo School of Medicine and Biomedical Sciences

Michael Stephen Freitas, MS is a member of the following medical societies: American College of Surgeons, American Medical Association, American Physical Therapy Association, and Medical Society of the State of New York

Disclosure: Nothing to disclose.

Philip Glick, MD, MBA  Professor, Departments of Surgery, Pediatrics, and Gynecology and Obstetrics, Vice-Chairperson for Finance and Development, Department of Surgery, State University of New York at Buffalo

Philip Glick, MD, MBA is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, American Medical Association, American Pediatric Surgical Association, American Thoracic Society, Association for Academic Surgery, Association for Surgical Education, Central Surgical Association, Federation of American Societies for Experimental Biology, Medical Society of the State of New York, Phi Beta Kappa, Physicians for Social Responsibility, Royal College of Surgeons of England, Sigma Xi, Society for Pediatric Research, Society for Surgery of the Alimentary Tract, Society of Critical Care Medicine, and Society of University Surgeons

Disclosure: Nothing to disclose.

Kara E Hennelly, MD  Fellow, Department of Pediatric Emergency Medicine, Children's Hospital Boston

Kara E Hennelly, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Michael S Katz, MD  Research Fellow, Department of Pediatric Surgery, St Christopher's Hospital for Children

Michael S Katz, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, and American Medical Student Association/Foundation

Disclosure: Nothing to disclose.

Robert Kelly, MD  Chairman, Department of Surgery, Departments of Surgery and Pediatrics, Children's Hospital of the King's Daughters; Associate Professor, Eastern Virginia Medical School

Robert Kelly, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Surgeons, American Medical Association, American Pediatric Surgical Association, American Society of Abdominal Surgeons, Medical Society of Virginia, Norfolk Academy of Medicine, and Southern Medical Association

Disclosure: Nothing to disclose.

Mark V Mazziotti, MD  Assistant Professor of Pediatric Surgery, Department of Surgery, Baylor College of Medicine, Texas Children's Hospital

Mark V Mazziotti, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, American Medical Association, American Pediatric Surgical Association, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Wayne Wolfram, MD, MPH  Associate Professor, Department of Emergency Medicine, Mercy St Vincent Medical Center

Wayne Wolfram, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Pediatrics, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Jeffrey J DuBois, MD  Chief of Children's Surgical Services, Division of Pediatric Surgery, Kaiser Permanente, Women and Children's Center, Roseville Medical Center

Jeffrey J DuBois, MD, is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, American Pediatric Surgical Association, and California Medical Association

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

David A Piccoli, MD  Chief of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia; Professor, University of Pennsylvania School of Medicine

David A Piccoli, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American Gastroenterological Association, and North American Society for Pediatric Gastroenterology and Nutrition

Disclosure: Nothing to disclose.

Harsh Grewal, MD, FACS, FAAP  Professor of Surgery and Pediatrics, Temple University School of Medicine; Chief, Section of Pediatric Surgery, Temple University School of Medicine

Harsh Grewal, MD, FACS, FAAP is a member of the following medical societies: American Academy of Pediatrics, American College of Surgeons, American Pediatric Surgical Association, Association for Surgical Education, Children's Oncology Group, Eastern Association for the Surgery of Trauma, International Pediatric Endosurgery Group, Society of American Gastrointestinal and Endoscopic Surgeons, Society of Laparoendoscopic Surgeons, and Southwestern Surgical Congress

Disclosure: Nothing to disclose.

Chief Editor

Carmen Cuffari, MD  Associate Professor, Department of Pediatrics, Division of Gastroenterology/Nutrition, Johns Hopkins University School of Medicine

Carmen Cuffari, MD is a member of the following medical societies: American College of Gastroenterology, American Gastroenterological Association, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Jeffrey R Tucker, MD.

References
  1. Narsule CK, Kahle EJ, Kim DS, Anderson AC, Luks FI. Effect of delay in presentation on rate of perforation in children with appendicitis. Am J Emerg Med. Oct 2011;29(8):890-3. [Medline].

  2. Rothrock SG, Pagane J. Acute appendicitis in children: emergency department diagnosis and management. Ann Emerg Med. Jul 2000;36(1):39-51. [Medline].

  3. Becker T, Kharbanda A, Bachur R. Atypical clinical features of pediatric appendicitis. Acad Emerg Med. Feb 2007;14(2):124-9. [Medline].

  4. Wiersma F, Toorenvliet BR, Bloem JL, Allema JH, Holscher HC. US examination of the appendix in children with suspected appendicitis: the additional value of secondary signs. Eur Radiol. Feb 2009;19(2):455-61. [Medline].

  5. Gracey D, McClure MJ. The impact of ultrasound in suspected acute appendicitis. Clin Radiol. Jun 2007;62(6):573-8. [Medline].

  6. Sulowski C, Doria AS, Langer JC, Man C, Stephens D, Schuh S. clinical outcomes in obese and normal-weight children undergoing ultrasound for suspected appendicitis. Acad Emerg Med. Feb 2011;18(2):167-73. [Medline].

  7. Lowe LH, Penney MW, Stein SM, Heller RM, Neblett WW, Shyr Y, et al. Unenhanced limited CT of the abdomen in the diagnosis of appendicitis in children: comparison with sonography. AJR Am J Roentgenol. Jan 2001;176(1):31-5. [Medline].

  8. Peck J, Peck A, Peck C, Peck J. The clinical role of noncontrast helical computed tomography in the diagnosis of acute appendicitis. Am J Surg. Aug 2000;180(2):133-6. [Medline].

  9. Mullins ME, Kircher MF, Ryan DP, Doody D, Mullins TC, Rhea JT, et al. Evaluation of suspected appendicitis in children using limited helical CT and colonic contrast material. AJR Am J Roentgenol. Jan 2001;176(1):37-41. [Medline].

  10. Callahan MJ, Rodriguez DP, Taylor GA. CT of appendicitis in children. Radiology. Aug 2002;224(2):325-32. [Medline].

  11. [Best Evidence] Kharbanda AB, Taylor GA, Fishman SJ, Bachur RG. A clinical decision rule to identify children at low risk for appendicitis. Pediatrics. Sep 2005;116(3):709-16. [Medline].

  12. Samuel M. Pediatric appendicitis score. J Pediatr Surg. Jun 2002;37(6):877-81. [Medline].

  13. [Best Evidence] Schneider C, Kharbanda A, Bachur R. Evaluating appendicitis scoring systems using a prospective pediatric cohort. Ann Emerg Med. Jun 2007;49(6):778-84, 784.e1. [Medline].

  14. Whyte C, Tran E, Lopez ME, Harris BH. Outpatient interval appendectomy after perforated appendicitis. J Pediatr Surg. Nov 2008;43(11):1970-2. [Medline].

  15. Andersson RE, Petzold MG. Nonsurgical treatment of appendiceal abscess or phlegmon: a systematic review and meta-analysis. Ann Surg. Nov 2007;246(5):741-8. [Medline].

Previous
Next
 
Ultrasonographic examination of the right lower quadrant reveals a greater than 6-mm noncompressible tubular structure shown in cross section. Discomfort was noted as the probe was depressed over this structure. A small amount of free fluid is also noted surrounding the appendix.
Ultrasonographic examination of the right lower quadrant reveals a greater than 6-mm noncompressible tubular structure shown in cross section. Discomfort was noted as the probe was depressed over this structure. A small amount of free fluid is also noted surrounding the appendix.
CT scan depicting a distended tubular structure descending into the pelvis and containing a round calcification (ie, an appendicolith).
CT scan revealing an enhancing tubular structure descending into the pelvis. Periappendiceal inflammation and streaking, so-called dirty fat, is noted surrounding the appendix.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.